EP3201203

CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    29.9.2015
  • :
    19.5.2021
  • :
    15778162.6
  • :
    28.9.2035
  • :
    CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE

29.9.2015
19.5.2021
  • :
    Takeda Pharmaceutical Company Limited
  • :
    1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
  • :
    ZHAO, Yuxin
  • :
    San Diego, California 92121, US
  • :
    201462056982 P
  • :
    29.9.2014
  • :
    US
  • :
    US2015052806
  • :
    29.9.2015
  • :
    C07D 498/08, A61K 31/5386, A61P 1/00, A61P 1/08, A61P 25/06, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/30